ribophorin
ii
type
transmembran
glycoprotein
er
segreg
rough
domain
organel
ribophorin
appear
part
transloc
apparatu
nascent
polypeptid
associ
membranebound
ribosom
particip
format
proteinac
network
within
er
membran
also
includ
compon
transloc
apparatu
ribophorin
highli
stabl
protein
lack
olink
sugar
contain
one
high
mannos
nlink
oligosaccharid
remain
endo
h
sensit
throughout
lifetim
previous
shown
tsao
n
e
ivessa
adesnik
sabatini
g
kreibich
j
cell
biol
coohtermin
truncat
variant
ribophorin
contain
first
amino
acid
lumin
domain
synthes
perman
transform
hela
cell
undergo
rapid
degrad
biphas
kinet
er
second
yet
unidentifi
nonlysosom
pregolgi
compart
show
cell
treat
brefeldin
bfa
molecul
undergo
rapid
oglycosyl
multistep
process
involv
rockefel
univers
press
cultur
cell
fix
first
dish
paraformaldehyd
glutaraldehyd
sodium
phosphat
buffer
ph
scrape
cell
left
fix
total
h
sampl
store
overnight
sodium
caeodylatr
buffer
process
cryomicrotomi
immunolabel
essenti
describ
tokuyasu
minor
modif
ivanov
et
al
de
lemoschiarandini
et
al
lectin
label
wga
rca
carri
describ
caiffith
et
al
use
antilectin
antibodi
protein
agold
section
infus
lr
white
acryl
resin
keller
et
al
examin
philip
electron
microscop
oper
kv
sequenti
addit
nacetylgalactosamin
galactos
termin
sialic
acid
residu
addit
olink
sugar
affect
newli
synthes
molecul
complet
soon
synthesi
half
time
rain
cell
intact
ribophorin
ii
also
underw
olink
glycosyl
presenc
bfa
molecul
modifi
short
time
period
immedi
synthesi
complet
modif
affect
fraction
newli
synthes
polypeptid
import
molecul
synthes
addit
bfa
modifi
oglycosyl
true
ribophorin
overexpress
hela
cell
although
significantli
less
stabl
nativ
polypeptid
control
cell
therefor
conclud
soon
synthesi
ribophorin
lose
suscept
reloc
golgi
enzym
effect
oglycosyl
like
consequ
conform
chang
ribophorin
occur
matur
although
exclud
rapid
integr
molecul
supramolecular
complex
er
membran
lead
inaccess
enzym
ibophorin
ii
two
well
character
highli
stabl
er
resid
glycoprotein
type
n
lumin
c
cytoplasm
transmembran
disposit
bear
high
mannos
oligosaccharid
lumin
segment
rosenfeld
et
al
harnikort
et
al
crimaudo
et
al
protein
segreg
rough
domain
er
kreibich
et
al
b
macantonio
et
al
amarcostesec
et
al
yung
shyeng
tsao
present
address
scheringplough
research
union
nj
akira
takatsuki
present
address
riken
institut
physic
chemic
research
wako
saitama
japan
appear
part
apparatu
effect
transit
cation
polypeptid
synthes
membranebound
ribosom
across
er
membran
yu
et
al
yu
et
al
ribophorin
compon
transloc
apparatu
signal
peptidas
receptor
signal
recognit
particl
signal
peptid
form
suprarnolecular
complex
proteinac
network
within
er
membran
treatment
rough
microsom
neutral
deterg
recov
togeth
associ
ribosom
rapidli
sediment
fraction
kreibich
et
al
marcantonio
et
al
amarcostesec
et
al
wiedmann
et
al
incorpor
ribophorin
compon
transloc
apparatu
network
may
respons
characterist
cistern
morpholog
rough
portion
er
quit
distinct
tubular
arrang
membran
smooth
portion
organel
kreibich
et
al
b
moreov
retent
compon
transloc
apparatu
er
may
simpli
result
fact
assembl
intramembran
network
gain
access
transport
vesicl
normal
flow
er
golgi
apparatu
previous
shown
tsao
et
al
truncat
variant
ribophorin
contain
first
amino
acid
lumin
domain
synthes
perman
transform
hela
cell
rapidli
degrad
nonlysosom
pathway
biphas
kinet
first
phase
degrad
begin
immedi
synthesi
complet
take
place
er
second
phase
howev
appear
requir
vesicular
transport
remain
molecul
er
second
compart
degrad
take
place
acceler
rate
two
degrad
compart
appear
fuse
cell
treat
brefeldin
bfa
truncat
ribophorin
degrad
monophas
kinet
rate
intermedi
two
normal
degrad
phase
tsao
et
al
bfa
antibiot
hirri
et
al
profoundli
affect
structur
golgi
apparatu
caus
backflow
golgi
enzym
er
fujiwara
et
al
lippincottschwartz
et
al
dom
et
al
ulmer
palad
report
show
presenc
bfa
newli
synthes
normal
ribophorin
truncat
ribophorin
variant
undergo
posttransl
modif
take
place
untreat
cell
ribophorin
undergo
oglycosyl
nlink
oligosaccharid
chain
ribophorin
ii
ribophorin
convert
endoglycosidas
h
endo
h
resist
form
howev
wherea
truncat
ribophorin
molecul
remain
access
reloc
golgi
enzym
throughout
lifetim
intact
ribophorin
ii
suscept
modifi
enzym
immedi
synthesi
would
appear
brief
period
intact
newli
synthes
molecul
conform
state
locat
bfa
treatment
permit
access
reloc
golgi
enzym
subsequ
matur
process
intact
ribophorin
becom
assembl
sequest
supramolecular
complex
truncat
variant
exclud
bfa
isol
crystallin
form
fungi
tamura
et
al
perman
hela
cell
transform
express
truncat
version
ribophorin
consist
amino
acid
lumin
domain
type
transmembran
glycoprotein
describ
tsao
et
al
procedur
cell
cultur
radioact
label
immunopreeipit
endo
h
treatment
page
either
gradient
gel
also
describ
previous
tsao
et
al
one
experi
see
legend
fig
cell
label
tritiumlabel
sugar
methionin
methionineand
glucosefre
mem
use
use
tritiumlabel
sugar
dri
savant
speed
vac
concentr
savant
instrument
inc
farmingdal
ny
dissolv
medium
concentr
cilml
unless
otherwis
indic
cultur
treat
bfa
preincub
methioninefre
medium
contain
drug
rain
puls
label
drug
present
cultur
medium
throughout
label
chase
period
concentr
gml
overexpress
ribophorin
rat
ribophorin
edna
excis
pgemi
vector
harnlkort
et
al
ligat
eukaryof
express
vector
kaufman
use
standard
procedur
sambrook
et
al
hela
cell
transient
transfect
construct
calcium
phosphat
precipit
method
dna
per
dish
synthesi
modif
stabil
ribophorin
analyz
h
transfect
glycosidas
treatment
immunoprecipit
protein
carri
accord
protocol
provid
supplier
protein
asepharos
bead
carri
immunoprecipit
boil
rain
buffer
contain
sd
mm
naphosph
ph
bead
sediment
supernatanl
contain
elut
protein
dilut
volum
contain
buffer
final
concentr
mm
edta
mm
naphosphnt
mm
naacet
ph
uml
trasylol
aliquot
treat
h
mock
treat
follow
glycosidas
gel
electrophoresi
oglycosidas
endonacetyladgalactosaminidas
diplococcu
pneumonia
musampl
bovin
test
mu
sampl
endoodgalactusidas
bacteriod
frasili
musampi
clfucosidas
beef
kidney
musampl
dilat
buffer
contain
mm
naacet
ph
naphosph
nacetylodglucosaminidas
beef
kidney
musampl
neuraminidas
clostridium
perfringen
musampl
subconllu
cultur
cell
incub
fresh
media
without
bfa
h
fix
glutaraldehyd
sodium
cacodyl
buffer
ph
vain
ice
cell
scrap
dish
sediment
postfix
glutaraldehyd
process
routin
em
thin
section
stain
uranyl
acet
lead
citrat
examin
electron
micro
scope
oper
kv
model
philip
electron
instrument
co
mahwah
nj
previous
shown
tsao
et
al
perman
transfect
hela
cell
express
truncat
form
ribophorin
lack
membran
cytoplasm
segment
consist
aminotermin
amino
acid
lumin
domain
truncat
molecul
degrad
biphas
kinet
furthermor
cell
treat
bfa
degrad
proceed
monophas
kinet
rate
constant
intermedi
two
rate
observ
control
cell
tsao
et
al
upon
care
analysi
appar
contrast
control
cell
presenc
bfa
appar
molecu
figur
bfainduc
modif
ribophorin
affect
nlink
oligosaccharid
remain
endo
h
sensit
also
occur
cell
treat
tunicamycin
cell
incub
methioninefre
medium
min
puls
label
methionin
min
chase
h
bfa
present
incub
immunoprecipit
sampl
taken
differ
time
chase
incub
endo
h
absenc
enzym
indic
analyz
sdspage
follow
fluorographi
r
z
indic
posit
polypeptid
gener
remov
nlink
oligosaccharid
endo
h
asterisk
alongsid
lane
band
lane
f
mark
posit
polypeptid
gener
endo
h
digest
posit
latter
mark
dot
lane
e
alongsid
lane
b
cell
preincub
tunicamycin
tzgml
h
methioninefre
medium
contain
tunicamycin
bfa
gml
min
puls
label
methionin
min
chase
min
presenc
drug
cg
control
cultur
treat
drug
harvest
immedi
puls
min
chase
b
immunoprecipit
obtain
analyz
sdspage
follow
fluorographi
modifi
form
ribophorin
polypeptid
observ
presenc
bfa
form
lack
nlink
oligosaccharid
lar
weight
label
molecul
underw
progress
increas
throughout
chase
fig
lane
c
e
g
k
min
chase
molecul
modifi
lane
c
min
posttransl
modif
essenti
complet
lane
g
prolong
chase
period
decay
pool
contain
heterogen
popul
molecul
repres
sever
close
space
electrophoret
band
fig
lane
k
ribophorin
truncat
variant
contain
singl
nlink
highmannos
oligosaccharid
chain
attach
cleav
endo
h
digest
rosenfeld
et
al
harnikort
et
al
tsao
et
al
determin
whether
appar
increas
molecular
mass
truncat
ribophorin
molecul
appear
bfatreat
cell
reflect
process
nlink
oligosaccharid
chain
effect
endo
h
treatment
protein
examin
shown
fig
endo
h
digest
increas
electrophoret
mobil
label
truncat
ribophorin
molecul
produc
bfatreat
cell
behavior
found
intact
ribophorin
shown
demonstr
nlink
oligosaccharid
chain
molecul
undergon
trim
addit
sugar
observ
protein
consequ
bfainduc
backflow
golgi
enzym
er
lippincottschwartz
dom
et
al
howev
deglycosyl
truncat
product
still
higher
molecular
weight
produc
endo
h
digest
label
molecul
present
immedi
puls
yet
undergon
bfainduc
posttransl
modif
fig
compar
r
r
demonstr
latter
modif
affect
part
ribophorin
molecul
nlink
oligosaccharid
chain
bfainduc
modif
ribophorin
involv
even
requir
presenc
nlink
oligosaccharid
chain
definit
establish
find
fig
b
bfa
treatment
led
decreas
electrophoret
mobil
normal
full
length
truncat
molecul
even
synthes
presenc
tunicamycin
drug
prevent
addit
nlink
oligosaccharid
chain
newli
synthes
polypeptid
takatsuki
et
al
moreov
experi
appar
endogen
intact
ribophorin
molecul
also
undergo
similar
decreas
electrophoret
mobil
although
fraction
popul
newli
synthes
nativ
ribophorin
molecul
eventu
modifi
fig
b
r
possibl
bfatreat
cell
ribophorin
molecul
modifi
addit
phosphat
sulfat
group
elimin
find
prolong
incub
medium
contain
radioact
phosphat
capasso
et
al
sulfat
hutmer
result
detect
label
either
intact
truncat
ribophorin
molecul
result
shown
therefor
examin
possibl
modifi
ribophorin
acquir
olink
oligosaccharid
normal
present
molecul
first
effect
variou
glycosidas
affect
core
sugar
nlink
oligosaccharid
electrophoret
mobil
modifi
ribophorin
investig
fig
digest
enzym
card
differ
time
chase
sinc
olink
chain
grow
sequenti
addit
monosaccharid
unit
sadler
progress
alter
suscept
cleavag
specif
enzym
min
chase
fig
lane
e
neither
oglycosidas
remov
olink
oligosaccharid
termin
galactos
residu
umemoto
et
al
fig
lane
substanti
increas
electrophoret
mobil
modifi
molecul
appar
molecular
mass
molecul
howev
still
higher
protein
synthes
control
cell
fig
compar
lane
e
lane
h
appear
therefor
modifi
molecul
contain
olink
oligosaccharid
intern
galactos
residu
neuraminldas
enzym
cleav
termin
sialic
acid
residu
alreadi
detect
effect
molecul
obtain
min
chase
fig
lane
f
appli
sampl
chase
min
complet
elimin
slower
migrat
compon
modifi
ribophorin
popul
correspond
diffus
upper
portion
band
fig
compar
lane
k
noteworthi
even
remov
termin
sialic
acid
residu
neuraminldas
oligosaccharid
chain
remain
resist
oglycosidas
fig
compar
lane
k
l
data
indic
galactos
residu
chain
still
cover
distal
sugar
molecul
contain
sugar
part
nlink
oligosaccharid
could
directli
demonstr
bfatreat
cell
preincub
tunicamycin
suppress
nglycosyl
experi
fig
cell
incub
min
media
contain
either
glucosamin
metabol
precursor
nacetyl
galactosamin
galactos
mannos
latter
serv
control
verifi
effect
tunicamycin
inhibit
nglycosyl
parallel
cultur
cell
label
condit
methionln
incub
period
display
full
rang
molecul
variou
stage
modif
fig
lane
show
molecul
encompass
molecular
mass
rang
kd
seem
like
fastest
migrat
compon
correspond
total
unglycosyl
polypeptid
contrast
situat
methionln
sugar
precursor
incorpor
slower
migrat
form
truncat
ribophorin
molecul
characterist
bfatreat
cell
fig
lane
b
c
two
slowli
migrat
speci
label
glucosamin
slower
label
galactos
label
pattern
would
expect
nacetylgalactosamin
deriv
glucosamin
attach
directli
oglycosid
bond
serin
threonin
residu
galactos
residu
subsequ
ad
sadler
cell
incub
mannos
trace
amount
radioact
incorpor
molecul
occur
modifi
molecul
lowest
electrophoret
mobil
given
fact
nine
mannos
residu
present
core
nlink
oligosaccharid
ckornfeld
kornfeld
low
incorpor
mannos
probabl
reflect
low
residu
level
nglycosyl
presenc
tunicamycin
low
degre
convers
mannos
label
sugar
strike
bfatreat
cell
incub
min
sugar
precursor
incorpor
endogen
intact
ribophorin
molecul
undetect
fig
lane
b
despit
fact
amount
nativ
protein
cell
measur
immunoblot
much
higher
truncat
molecul
shown
sinc
pulselabel
experi
methionln
bfatreat
cell
fig
show
substanti
proport
newli
synthes
intact
ribophorin
molecul
modifi
subsequ
chase
lack
detect
incorpor
radioact
sugar
intact
ribophorin
indic
newli
synthes
preexist
ribophorin
molecul
serv
substrat
oglycosyl
system
sinc
ribophorin
synthes
approxim
lower
rate
oglycosyl
form
newli
made
ribophorin
molecul
may
easili
detect
label
tritiat
sugar
f
hl
puls
label
methionin
min
chase
min
indic
control
cultur
lane
g
incub
methioninefre
medium
label
chase
absenc
bfa
immunoprecipit
obtain
cell
lysat
incub
h
lane
cf
jl
without
lane
b
gi
follow
glycosidas
oglycosidas
endonacetylavgalactosaminidas
enzym
dgalactosidas
enzym
enzym
neuraminidas
enzym
incub
sampl
analyz
sdspage
follow
fluorographi
behavior
ribophorin
ii
resid
glycoprotein
er
membran
transmembran
disposit
ribophorin
crimaudo
et
al
pirozzi
et
al
also
examin
bfatreat
cell
must
first
note
control
hela
cell
newli
synthes
ribophorin
ii
molecul
acquir
nlink
oligosaccharid
chain
fig
ri
vs
rii
lane
therefor
sensit
endo
h
treatment
lane
b
pulsechas
experi
demonstr
bfatreat
cell
type
ribophorin
ii
molecul
bear
rii
well
lack
rh
nlink
oligosaccharid
convet
slowli
migrat
form
moreov
contrast
situat
ribophorin
chase
period
modifi
molecul
almost
complet
resist
endo
h
digest
fig
compar
lane
e
f
indic
high
mannos
nlink
oligosacchar
ribophorin
ii
process
reloc
golgi
enzym
olink
sugar
ad
ribophorin
ii
polypeptid
whether
contain
nlink
oligosaccharid
addit
olink
sugar
ribophorin
ii
bfatreat
cell
confirm
find
drug
led
appear
slowli
migrat
form
even
cell
treat
tunica
addit
bfa
tzgml
rain
label
one
bfatreat
sampl
e
f
incub
chase
medium
contain
bfa
h
lysi
immunoprecipit
antiribophorin
ii
antibodi
sampl
divid
two
equal
aliquot
either
mock
treat
c
e
treat
endo
h
b
f
analyz
sdspage
fluorographi
hela
cell
cultur
also
pretreat
tunicamycin
h
one
cultur
treat
bfa
min
label
h
methionin
rii
membraneinsert
complet
unglycosyl
ribophorin
ii
polypeptid
degre
alway
found
control
cell
form
present
cell
treat
tunicamycin
absenc
bfa
ri
ribophorin
ii
molecul
contain
high
mannos
endo
h
sensit
nlink
oligosaccharid
chain
found
normal
er
membran
rira
rfro
oglycosyl
form
found
bfatreat
cell
deriv
rii
rii
presenc
bfa
nlink
oligosaccharid
rii
oglycosyl
deriv
convert
endo
h
resist
form
mycin
suppress
nglycosyl
fig
lane
g
h
case
also
contrast
situat
ribophorin
two
distinct
modifi
form
ribophorin
ii
produc
like
correspond
molecul
contain
differ
number
olink
oligosaccharid
chain
presenc
galactos
sialic
acid
residu
modifi
ribophorin
molecul
indic
bfa
treatment
respect
glycosyltransferas
normauy
present
transcisterna
golgi
apparatu
kornfeld
kornfeld
cum
et
al
elhamm
kornfeld
found
er
could
result
either
reloc
preexist
golgi
enzym
demonstr
omannosidas
h
galactosyltransferas
lippincottschwartz
et
al
accumul
newli
synthes
glycosyltransferas
fail
leav
er
presenc
drug
distinguish
possibl
effect
bfa
assess
cell
puls
label
pss
methionin
incub
protein
synthesi
inhibitor
cycloheximid
min
period
suffici
allow
egress
er
newli
synthes
protein
destin
golgi
apparatu
shown
fig
even
condit
bfa
treatment
result
appear
slowli
migrat
form
kinet
absenc
cycloheximid
therefor
conclud
modif
induc
bfa
carri
preexist
glycosyltransferas
reloc
golgi
apparatu
er
result
treatment
drug
may
also
note
fig
treatment
cycloheximid
appear
slow
degrad
molecul
appear
transgolgi
compon
er
result
bfa
treatment
could
also
demonstr
em
use
lectin
label
techniqu
immunogold
detect
procedur
ultrathin
frozen
section
gdflith
et
al
agreement
previou
report
fujiwara
et
al
figur
posttransl
modif
observ
bfatreat
cell
etfeet
preexist
enzym
cultur
cell
puls
label
methionin
min
time
two
cultur
place
ice
lane
n
cultur
incub
rain
complet
chase
medium
hm
without
bg
cyclobeximid
g
ml
chase
bfa
ad
incub
continu
min
chase
time
indic
cell
lyse
sdscontain
buffer
process
immunoprecipi
sdspage
follow
fluorographi
lippincottschwartz
et
al
ulmer
palad
bfa
led
profound
chang
structur
golgi
apparatu
treatment
drug
appar
reduc
cluster
vesicular
tubular
element
locat
near
partli
rough
partli
smooth
er
cistema
typic
appear
transit
element
jamieson
palad
expect
previou
studi
tartakoff
vassal
control
hela
cell
figur
bfa
treatment
hela
cell
lead
appear
wga
bind
site
er
nuclear
envelop
ultrathin
frozen
section
control
cell
cell
treat
bfa
tgrnl
min
b
h
c
incub
wga
site
lectin
bind
detectexl
use
antiwga
antibodi
protein
agold
control
cell
nuclear
envelop
ne
er
label
dens
label
observ
transgolgi
cisterna
ga
plasma
membran
pm
within
mitt
bfa
treatment
b
wga
bind
observ
nuclear
envelop
er
well
profil
correspond
remnant
golgi
apparatu
arg
arrow
h
bfa
treatment
er
ne
much
intens
label
wga
recogn
sialic
acid
expos
nacetyl
glucosamin
residu
bhavanandan
katlic
label
intens
transcisterna
golgi
apparatu
membran
lumin
content
er
fig
hand
cell
treat
bfa
time
short
min
fig
b
h
fig
c
wga
bind
situ
present
throughout
er
nuclear
envelop
well
appar
remnant
golgi
apparatu
fig
similar
result
obtain
lectin
rca
recogn
termin
galactos
residu
baenzig
fiet
cell
treat
cycloheximid
h
addit
bfa
deplet
eli
newli
synthes
golgi
protein
result
shown
find
accord
preced
biochem
demonstr
bfa
induc
redistribut
oglycosyl
enzym
transregion
golgi
apparatu
galactosyland
sialyltransferas
er
shown
truncat
ribophorin
molecul
synthes
brief
rnin
puls
eventu
becom
posttransl
modifi
fig
chase
period
presenc
bfa
even
drug
ad
rain
label
fig
hand
intact
ribophorin
molecul
synthes
brief
puls
undergo
posttransl
modif
fig
b
moreov
cell
incub
label
monosaccharid
fig
oglycosyl
previous
synthes
intact
ribophorin
molecul
appear
take
place
signific
extent
suggest
ribophorin
molecul
suscept
oglycosyl
limit
period
synthesi
seem
like
could
correspond
time
requir
newli
synthes
polypeptid
undergo
conform
chang
andor
eventu
becom
incorpor
proteinac
network
rer
matur
protein
shown
contain
kreibich
et
al
b
yu
et
al
estim
time
interv
newli
synthes
ribophorin
molecul
access
oglycosyl
system
hela
cell
label
h
presenc
absenc
bfa
extent
posttransl
modif
occur
subsequ
chase
period
presenc
drug
assess
rel
long
label
period
facilit
detect
label
ribophorin
molecul
modifi
full
length
polypeptid
detect
cell
label
presenc
drug
fig
failur
bfa
caus
modif
previous
label
ribophorin
molecul
howev
could
result
part
time
requir
drug
exert
effect
golgi
enzym
reach
er
latter
recent
estim
consider
less
min
donaldson
et
al
accord
observ
appear
lectin
bind
site
er
within
rain
bfa
treatment
fig
b
sinc
ribophorin
stabl
protein
weakli
label
short
puls
difficult
carri
type
experi
shorter
label
period
obtain
accur
kinet
modif
intact
figur
bfatreat
cell
intact
ribophorin
ribophorin
ii
molecul
posttransl
glycosyl
limit
period
synthesi
hela
cell
c
hela
cell
transient
overexpress
ribophorin
b
preincub
methioninefre
medium
min
lane
ac
without
dg
bfa
tgml
label
ss
methionin
h
presenc
ac
absenc
dg
drug
cultur
g
place
ice
immedi
label
period
wherea
other
incub
chase
medium
contain
bfa
h
b
e
h
c
f
immunoprecipit
obtain
cell
lysat
antibodi
ribophorin
b
ribophorin
ii
c
analyz
sdspage
follow
fluorographi
label
band
mark
use
abbrevi
introduc
legend
fig
molecul
assum
avail
modifi
enzym
intact
truncat
molecul
modifi
kinet
conclud
within
rain
less
synthesi
complet
ribophorin
molecul
longer
suscept
modif
reloc
golgi
enzym
similar
experi
examin
behavior
ribophotin
ii
fig
c
show
like
ribophorin
bfa
treatment
initi
puls
newli
synthes
label
ribophorin
ii
molecul
undergo
modif
carri
reloc
golgi
enzym
therefor
ribophorin
suscept
action
enzym
limit
time
period
synthesi
ribophorin
rapidli
becam
resist
action
golgi
glycosyltransferas
consequ
incorpor
oligomer
assembl
one
would
expect
overexpress
one
protein
level
far
exceed
compon
assembl
would
lead
much
effici
oglycosyl
surprisingli
fulllength
ribophorin
transient
overexpress
hela
cell
oglycosyl
observ
bfa
treatment
initi
complet
ribophorin
synthesi
fig
b
lane
df
furthermor
level
oglycosyl
ribophorin
observ
synthesi
occur
presenc
bfa
markedli
chang
fig
b
lane
ac
compar
seen
control
cell
ig
lane
ac
result
suggest
ribophorin
integr
heterooligomer
complex
undergo
conform
chang
render
resist
oglycosyl
bfatreat
cell
previous
observ
ribophorin
longliv
protein
rer
rosenfeld
et
al
see
also
fig
comparison
degrad
rate
ribophorin
transfect
cell
control
cell
reveal
overexpress
molecul
much
unstabl
fig
b
sinc
h
chase
approxim
equal
amount
label
ribophorin
remain
transfect
control
cell
would
appear
overexpress
molecul
turnov
halflif
h
less
note
transient
transfect
experi
cell
express
foreign
protein
express
cell
ribophorin
synthes
time
control
level
find
overexpress
portion
ribophorin
molecul
degrad
significantli
faster
endogen
express
polypeptid
consist
notion
high
stabil
endogen
ribophorin
result
integr
oligomer
assembl
ribophorin
ii
well
compon
transloc
apparatu
appear
repres
class
resid
er
membran
protein
contrast
well
studi
er
polypeptid
protein
adenoviru
pbo
et
al
nilsson
et
al
udpglucuronosyltransferas
jackson
et
al
contain
retent
signal
extrem
coohtermini
jackson
et
al
ribophorin
form
larg
macromolecular
assembl
complex
within
er
membran
kreibich
et
al
b
yu
et
al
seem
like
retent
er
simpli
result
fact
incorpor
complex
gain
access
vesicl
mediat
transport
golgi
apparatu
protein
synthes
er
thu
segreg
protein
form
larg
macromolecular
complex
although
result
true
retent
mechan
would
requir
signal
common
instead
retent
protein
might
involv
interact
anoth
specif
compon
macromolecular
assembl
true
retent
mechan
rather
mechan
involv
retriev
golgi
apparatu
respons
segreg
mani
protein
er
includ
ribophorin
first
suggest
find
nlink
oligosaccharid
chain
er
protein
undergo
convers
complex
form
resist
endo
h
capabl
bind
lectin
wga
rca
process
requir
action
enzym
locat
golgi
apparatu
rodriguezboulan
et
al
b
rosenfeld
et
al
brand
et
al
yamamoto
et
al
valid
argument
particular
protein
howev
rest
premis
protein
could
serv
substrat
golgi
enzym
becom
access
current
work
demonstr
nglycosyl
ribophorin
ii
molecul
normal
remain
sensit
endo
h
bfatreat
cell
becom
resist
digest
enzym
similar
behavior
recent
observ
anoth
er
resid
protein
figur
ribophorin
overexpress
hela
ceil
becom
unstabl
hela
ceil
hela
cell
transient
overexpress
ribophorin
b
incub
methioninefre
medium
min
puls
label
methionin
h
chase
h
chase
time
indic
cell
lyse
sdscontain
buffer
process
immunoprecipit
sdspage
follow
fluorographi
lippincottschwartz
et
al
regard
find
bfatreat
cell
nlink
oligosaccharid
chain
ribophorin
remain
endo
h
sensit
clearli
demonstr
access
enzym
could
effect
convers
endo
h
resist
form
suffici
ensur
modif
take
place
inde
conform
glycoprotein
may
well
determin
suscept
sugar
chain
action
reloc
modifi
enzym
addit
exclud
singl
nlink
oligosaccharid
chain
ribophorin
would
acquir
resist
digest
endo
h
molecul
would
pass
golgi
stack
order
fashion
instead
expos
golgi
glycosyltransferas
bfainduc
ergolgi
hybrid
compart
fact
observ
unpublish
observ
five
nlink
oligosaccharid
chain
hemagghtinin
influenza
normal
convert
endo
h
resist
form
passag
protein
golgi
apparatu
modifi
reloc
golgi
enzym
protein
remain
er
bfatreat
cell
also
found
ribophorin
normal
acquir
olink
oligosaccharid
bfa
treatment
demonstr
inde
serv
substrat
enzym
carri
modif
therefor
absenc
drug
must
expos
oglycosyl
involv
addit
nacetylgalactosamin
serin
threonin
residu
polypeptid
backbon
follow
linkag
galactos
sialic
acid
sadier
exact
subcellular
locat
nacetyl
galactosaminyl
transferas
initi
growth
olink
oligosaccharid
chain
establish
although
rel
rapid
kinet
modif
take
place
tooz
et
al
well
fact
certain
mutant
low
densiti
lipoprotein
ldl
receptor
fail
transvers
golgi
apparatu
nevertheless
acquir
olink
sugar
cum
et
al
suggest
enzym
could
locat
pregolgi
compart
fact
recent
studi
glycoprotein
mous
hepat
coronaviru
viru
tooz
et
al
conclud
addit
nacetylgalactosamin
protein
occur
pregolgi
compart
also
site
bud
virion
lumen
endomembran
system
morpholog
resembl
transit
element
vesicl
found
er
golgi
apparatu
sinc
ribophorin
ii
well
truncat
ribophorin
variant
undergo
oglycosyl
bfatreat
cell
conclud
normal
circumst
molecul
even
reach
intermedi
compart
may
salvag
compart
kdelcontain
lumin
protein
escap
er
retriev
organel
pelham
reinforc
conclus
segreg
ribophorin
ii
involv
retriev
mechan
note
inde
oglycosyl
take
place
salvag
compart
one
would
expect
lumin
er
protein
recycl
compart
would
contain
olink
sugar
predict
test
experiment
observ
bfatreat
ceil
galactos
residu
incorpor
truncat
ribophorin
variant
neuraminidas
treatment
increas
electrophoret
mobil
protein
provid
biochem
evid
oligosaccharidemodifi
enzym
transregion
golgi
apparatu
becom
reloc
er
bfa
treatment
presenc
galactosyltransferas
er
bfatreat
cell
previous
demonstr
immunocytochem
lippincottschwartz
et
al
well
find
receptor
molecul
synthes
presenc
drug
bind
rcai
lectin
column
chege
pfeffer
sialic
acid
residu
present
truncat
ribophorin
remov
neuraminidas
must
part
olink
oligosaccharid
chain
sinc
protein
remain
endo
h
sensit
therefor
singl
nlink
oligosaccharid
contain
sialic
acid
strike
reloc
golgi
compon
caus
bfa
also
manifest
appear
bind
site
lectin
rcai
wga
er
former
lectin
bind
expos
galactos
residu
baenzig
fiet
latter
expos
nacetyl
glucosamin
sialic
acid
residu
bhavanandan
katlic
expect
previou
studi
myeloma
cell
tartakoff
vassal
found
control
hela
cell
intracellular
bind
site
lectin
almost
exclus
present
transregion
golgi
apparatu
signific
extent
er
nuclear
envelop
bfa
treatment
howev
even
cell
protein
synthesi
inhibit
cycloheximid
lectin
intens
label
er
nuclear
envelop
electron
microscop
result
mark
contrast
immunofluoresc
observ
lippincottschwartz
et
al
cultur
normal
rat
kidney
nrk
cell
bfa
treatment
lead
reloc
wga
bind
site
later
work
author
observ
bfa
caus
complet
reloc
er
transgolgi
enzym
galactosyltransferas
therefor
suggest
wga
bind
site
reloc
predominantli
local
transgolgi
network
lippincottschwartz
et
al
may
inde
case
nrk
cell
also
possibl
lectin
bind
site
appear
er
bfa
treatment
correspond
redistribut
previous
exist
golgi
glycoprotein
rather
extent
may
vari
cell
type
site
may
creat
sialyltransferas
reloc
medial
transgolgi
region
oper
er
resid
protein
well
reloc
cisand
medial
golgi
protein
consid
locat
lectin
bind
site
within
golgi
apparatu
one
must
note
integr
membran
protein
confin
cisand
medial
golgi
cisterna
identifi
contain
sialic
acid
residu
nlink
olink
oligosaccharid
chain
yuan
et
al
led
altern
suggest
protein
either
modifi
transgolgi
network
return
proxim
region
golgi
apparatu
yet
uncharacter
sialyltransferas
locat
cisand
medial
cisterna
strike
observ
studi
bfatreat
cell
newli
synthes
preexist
intact
ribophorin
molecul
suscept
oglycosyl
reloc
golgi
enzym
consequ
small
fraction
total
cell
complement
endogen
ribophorin
acquir
modif
intact
ribophorin
molecul
receiv
modif
label
puls
brief
period
synthesi
addit
overexpress
fulllength
ribophorin
molecul
synthes
excess
stoichiometr
amount
present
untransfect
cell
also
suscept
oglycosyl
limit
period
synthesi
hand
truncat
ribophorin
molecul
suspect
oglycosyl
throughout
lifetim
quantit
modifi
first
period
addit
bfa
seem
like
differ
intact
truncat
ribophorin
result
conform
chang
intact
polypeptid
molecul
undergo
soon
synthesi
possibl
also
sequestr
supramolecular
assembl
er
membran
respons
retent
within
organel
rel
rapid
degrad
fulllength
ribophorin
molecul
express
level
stoichiometr
amount
compon
supramolecular
assembl
rer
membran
like
consequ
failur
assembl
normal
would
analog
rapid
turnov
monomer
compon
multimer
protein
observ
individu
subunit
synthes
excess
bonifacino
lippincottschwartz
